Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19

The clinical manifestations of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),1 range from asymptomatic, mild pneumonia to acute respiratory distress syndrome (ARDS).2 An epidemiological study with 72,314 patients has reported that around 4.7% of patients with COVID-19 developed ARDS, and the mortality rate in these patients was up to 49%.3 Most patients surviving from ARDS caused by other coronaviruses like SARS-CoV and Middle East respiratory syndrome coronavirus suffered from impaired pulmonary function and radiological abnormalities.
Source: Journal of Infection - Category: Infectious Diseases Source Type: research